Becton Dickinson Other Long-Term Assets 2010-2024 | BDX
Becton Dickinson other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Becton Dickinson other long-term assets for the quarter ending September 30, 2024 were $2.615B, a 25.84% increase year-over-year.
- Becton Dickinson other long-term assets for 2024 were $2.615B, a 25.84% increase from 2023.
- Becton Dickinson other long-term assets for 2023 were $2.078B, a 12.45% increase from 2022.
- Becton Dickinson other long-term assets for 2022 were $1.848B, a 4.99% decline from 2021.
Becton Dickinson Annual Other Long-Term Assets
(Millions of US $) |
| 2024 |
$2,615 |
| 2023 |
$2,078 |
| 2022 |
$1,848 |
| 2021 |
$1,945 |
| 2020 |
$1,687 |
| 2019 |
$1,088 |
| 2018 |
$1,078 |
| 2017 |
$1,007 |
| 2016 |
$824 |
| 2015 |
$717 |
| 2014 |
$488 |
| 2013 |
$487 |
| 2012 |
$500 |
| 2011 |
$445 |
| 2010 |
$488 |
| 2009 |
$465 |
Becton Dickinson Quarterly Other Long-Term Assets
(Millions of US $) |
| 2024-09-30 |
$2,615 |
| 2024-06-30 |
$2,401 |
| 2024-03-31 |
$2,399 |
| 2023-12-31 |
$2,259 |
| 2023-09-30 |
$2,078 |
| 2023-06-30 |
$2,059 |
| 2023-03-31 |
$1,994 |
| 2022-12-31 |
$1,955 |
| 2022-09-30 |
$1,848 |
| 2022-06-30 |
$1,793 |
| 2022-03-31 |
$1,866 |
| 2021-12-31 |
$1,945 |
| 2021-09-30 |
$1,945 |
| 2021-06-30 |
$1,821 |
| 2021-03-31 |
$1,758 |
| 2020-12-31 |
$1,801 |
| 2020-09-30 |
$1,687 |
| 2020-06-30 |
$1,632 |
| 2020-03-31 |
$1,509 |
| 2019-12-31 |
$1,573 |
| 2019-09-30 |
$1,088 |
| 2019-06-30 |
$1,063 |
| 2019-03-31 |
$1,061 |
| 2018-12-31 |
$1,062 |
| 2018-09-30 |
$1,078 |
| 2018-06-30 |
$984 |
| 2018-03-31 |
$1,159 |
| 2017-12-31 |
$1,184 |
| 2017-09-30 |
$1,007 |
| 2017-06-30 |
$938 |
| 2017-03-31 |
$948 |
| 2016-12-31 |
$927 |
| 2016-09-30 |
$824 |
| 2016-06-30 |
$712 |
| 2016-03-31 |
$694 |
| 2015-12-31 |
$727 |
| 2015-09-30 |
$717 |
| 2015-06-30 |
$674 |
| 2015-03-31 |
$696 |
| 2014-12-31 |
$506 |
| 2014-09-30 |
$488 |
| 2014-06-30 |
$502 |
| 2014-03-31 |
$483 |
| 2013-12-31 |
$502 |
| 2013-09-30 |
$487 |
| 2013-06-30 |
$506 |
| 2013-03-31 |
$493 |
| 2012-12-31 |
$513 |
| 2012-09-30 |
$500 |
| 2012-06-30 |
$463 |
| 2012-03-31 |
$451 |
| 2011-12-31 |
$407 |
| 2011-09-30 |
$445 |
| 2011-06-30 |
$492 |
| 2011-03-31 |
$491 |
| 2010-12-31 |
$481 |
| 2010-09-30 |
$488 |
| 2010-06-30 |
$487 |
| 2010-03-31 |
$481 |
| 2009-12-31 |
$486 |
| 2009-09-30 |
$465 |
| 2009-06-30 |
$383 |
| 2009-03-31 |
$338 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$68.842B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
